As announced in our third-quarter presentation on November 27, 2024, and reaffirmed in our fourth-quarter presentation on February 12, 2025, Avance Gas has completed the sale of all its assets and has ...

Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding ...

Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding from National Health Service ...